产品中心Cell Resources
联系我们CONTACT US
400-999-210024小时服务热线
产品概述
名称 | HuCC-T1 (人胆管癌细胞) (STR鉴定正确) |
别称 | HuCCT-1; HUCCT-1; HUCC-T1; HUCCT1; HuCCT1 |
种属 | 人 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养方案A(默认) |
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
|
推荐传代比例 | 1:2 |
推荐换液频率 | 2-3次/周 |
年龄(性别) | 男性;56岁 |
组织来源 | 胆管,腹水转移 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 肝胆癌细胞 |
生物安全等级 | BSL-1 |
倍增时间 | ~55 hours |
保藏机构 | JCRB; JCRB0425 RCB; RCB1960 TKG; TKG 0389 |
STR鉴定
-
STR位点信息
Amelogenin X,Y CSF1PO 11,12 D2S1338 17,18 D3S1358 15 D5S818 12,13 D7S820 10,11 D8S1179 10 D13S317 11,13 D16S539 11,12 D18S51 13 D19S433 13 D21S11 31 FGA 20,23 PentaD 10 PentaE 15,18 TH01 7,10 TPOX 8 vWA 18 D6S1043 13 D12S391 18,20 D2S441 10,11 -
STR鉴定图
-
参考文献
-
Computational analyses to reveal the key determinants of the high malignancy level of cholangiocarcinoma (2025-01-10)
期刊:Journal of Translational Internal Medicine
影响因子 :4.7
引用产品: RBE 细胞 , HuCC-T1 细胞 , 青霉素-链霉素溶液(双抗),100×
-
AMDHD1 acts as a tumor suppressor and contributes to activation of TGF-β signaling pathway in cholangiocarcinoma (2024-08-14)
期刊:CELL DEATH AND DIFFERENTIATION
DOI:10.1038/s41418-024-01361-y
影响因子 :13.7
引用产品: RBE 细胞 , HCCC-9810 细胞 , CCLP-1 细胞 , HuCC-T1 细胞 , QBC939 细胞 , SNU-869 细胞
-
CLK1 Activates YAP to Promote Intrahepatic Cholangiocarcinogenesis (2024-12-18)
期刊:CANCER RESEARCH
DOI:10.1158/0008-5472.CAN-24-0147
影响因子 :12.5
引用产品: HuCC-T1 细胞 , RBE 细胞 , HCCC-9810 细胞 , Hep 3B2.1-7 细胞 , HFL1 细胞 , HuH-1 细胞 , HuH-7 细胞
-
Gut microbiota regulates the ALK5/NOX1 axis by altering glutamine metabolism to inhibit ferroptosis of intrahepatic cholangiocarcinoma cells (2024-04-05)
期刊:BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
DOI:10.1016/j.bbadis.2024.167152
影响因子 :6.2
引用产品: HuCC-T1 细胞
-
ETV4 promotes the progression of cholangiocarcinoma by regulating glycolysis via the TGF-β signaling (2024-06-14)
期刊:Translational Oncology
DOI:10.1016/j.tranon.2024.102035
影响因子 :4.5
引用产品: HuCC-T1 细胞 , RBE 细胞 , HCCC-9810 细胞
-
Protein regulator of cytokinesis 1 accentuates cholangiocarcinoma progression via mTORC1-mediated glycolysis (2024-02-28)
期刊:Human Cell
DOI:10.1007/s13577-024-01032-7
影响因子 :4.3
引用产品: HCCC-9810 细胞 , HuCC-T1 细胞 , RBE 细胞
-
UBA3 promotes the occurrence and metastasis of intrahepatic cholangiocarcinoma through MAPK signaling pathway: UBA3 promotes the occurrence and metastasis of ICC (2024-01-31)
期刊:ACTA BIOCHIMICA ET BIOPHYSICA SINICA
影响因子 :3.3
引用产品: HCCC-9810 细胞 , RBE 细胞 , QBC939 细胞 , HuCC-T1 细胞
-
Durvalumab and T-DXd Synergistically Promote Apoptosis of Cholangiocarcinoma Cells by Downregulating EGR1 Expression Through Inhibiting P38 MAPK Pathway (2024-11-28)
期刊:APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
DOI:10.1007/s12010-024-05112-0
影响因子 :3.1
引用产品: HuCC-T1 细胞
-
METTL3-mediated m6A modification promotes chemoresistance of intrahepatic cholangiocarcinoma by up-regulating NRF2 to inhibit ferroptosis in cisplatin-resistant cells (2024-11-01)
期刊:JOURNAL OF CHEMOTHERAPY
DOI:10.1080/1120009X.2024.2421700
影响因子 :1.9
引用产品: HuCC-T1 细胞 , RPMI-1640 培养基 , 特级胎牛血清 , HCCC-9810 细胞 , 青霉素-链霉素溶液(双抗),100×
-
Development of potent antibody drug conjugates against ICAM1+ cancer cells in preclinical models of cholangiocarcinoma (2023-09-16)
期刊:npj Precision Oncology
DOI:10.1038/s41698-023-00447-z
影响因子 :7.9
引用产品: HuCC-T1 细胞 , HCCC-9810 细胞
-
Targeting PKM2 improves the gemcitabine sensitivity of intrahepatic cholangiocarcinoma cells via inhibiting β-catenin signaling pathway (2023-11-22)
期刊:CHEMICO-BIOLOGICAL INTERACTIONS
影响因子 :5.1
引用产品: HuCC-T1 细胞
-
Identification of SPRYD4 as a tumour suppressor predicts prognosis and correlates with immune infiltration in cholangiocarcinoma (2023-05-04)
期刊:BMC CANCER
DOI:10.1186/s12885-023-10810-9
影响因子 :3.8
引用产品: HuCC-T1 细胞 , RBE 细胞 , CCLP-1 细胞 , huh28 细胞 , QBC939 细胞 , HCCC-9810 细胞
-
Hsa_circ_0019054 up-regulates HIF1A through sequestering miR-340–5p to promote the tumorigenesis of intrahepatic cholangiocarcinoma (2022-12-06)
期刊:HUMAN & EXPERIMENTAL TOXICOLOGY
影响因子 :3.3
引用产品: 人肝内胆管上皮细胞 , RBE 细胞 , HuCC-T1 细胞
FAQs
Q:{{item.question}}
A:
产品资料


识别码示意图